Bon Natural Life Limited Class A Ordinary Shares

BONNASDAQUSD
1.20 USD
0.02 (1.24%)AT CLOSE (11:59 AM EDT)
1.20
0.00 (0.08%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
1.20
0.00 (0.08%)
🟢Market: OPEN

Shares of Bon Natural Life Limited Class A Ordinary Shares (BON) are trading at $1.20. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Sep 23, 2026.

Open?$1.21
High?$1.22
Low?$1.15
Prev. Close?$1.21
Volume?12.2K
Avg. Volume?N/A
VWAP?$1.19
Bid / Ask
Bid?$1.00 × 100
Ask?$1.41 × 100
Spread?$0.41
Midpoint?$1.21
Valuation & Ratios
Market Cap?9.8M
Shares Out?6.1M
Float?6.1M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
Employees
96
Market Cap
9.8M
Industry
N/A
Listed
2021-06-24
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.27%Low
Short Interest?16.4K
Days to Cover?2.7
Free Float6.1M
Avg Daily Volume6.1K
Settlement Date2026-08-31